shkspr

Long | Edit

看多
shkspr 已更新   
NASDAQ:EDIT   Editas Medicine, Inc.
EDIT
Possible Scenario: LONG
Evidence: Price Action
TP1 ~68$,
This is my idea and could be wrong 100%
*Call options 16 April, Strike 70$
交易進行
評論:
Price target remained the same, correction is done and we are going to hit the target
交易進行:
consolidated and break-out is imminent

no pain, no gain
Unveiling illusions, revealing wealth
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。